Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1
Open Access
- 26 May 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Genetics
- Vol. 45 (7), 825-830
- https://doi.org/10.1038/ng.2646
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Chromatin remodeling by the CHD7 protein is impaired by mutations that cause human developmental disordersProceedings of the National Academy of Sciences of the United States of America, 2012
- Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing studyThe Lancet, 2012
- A genetic diagnostic approach to infantile epileptic encephalopathiesJournal of Clinical Neuroscience, 2012
- Patterns and rates of exonic de novo mutations in autism spectrum disordersNature, 2012
- Deletion of the RMGA and CHD2 genes in a child with epilepsy and mental deficiencyEuropean Journal of Medical Genetics, 2012
- Rare copy number variants are an important cause of epileptic encephalopathiesAnnals of Neurology, 2011
- Microdeletion of Chromosome 15q26.1 in a Child With Intractable Generalized EpilepsyPediatric Neurology, 2011
- Rare Deletions at 16p13.11 Predispose to a Diverse Spectrum of Sporadic Epilepsy SyndromesAmerican Journal of Human Genetics, 2010
- Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005–2009Epilepsia, 2010
- The Chd family of chromatin remodelersMutation research. Reviews in mutation research, 2007